Skip to content

Is Bronchoscopy Necessary in the Preoperative Workup of GGO Lung Cancer?(ECTOP-1005)

Is Bronchoscopy Necessary in the Preoperative Workup of Ground Glass Opacity Featured Lung Cancer?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03591445
Enrollment
615
Registered
2018-07-19
Start date
2018-11-06
Completion date
2020-06-30
Last updated
2023-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Nodule, Solitary

Brief summary

This study is one of Eastern Cooperative Thoracic Oncology Projects (ECTOP-1005). It aims to evaluate the role of flexible bronchoscopy in the pre-operative workup of ground glass opacity featured lung cancer. All enrolled patients receive the flexible bronchoscopy examination before surgery. Investigators observe the intra-bronchial findings of bronchoscopy and the impact of these findings on established surgical plan.

Detailed description

The appropriateness of routine use of bronchoscopy in the operative workup of a solitary pulmonary nodule(SPN) is debatable. Options expressed in the literature vary from routine preoperative bronchoscopy having no role in obtaining tissue diagnosis in small SPNs to it begin very useful in determining underlying etiology and surgical strategy. The American College of Chest Physicians(ACCP)guidelines recommend bronchoscopy only if air-bronchogram is present or if operator has expertise with newer guided techniques. Previous study showed that bronchoscopy is not indicated in SPNs that present with ground-glass opacity on CT. The purpose of this analysis is to define that role by examining in GGO patients (1)intra-bronchial findings (2)impact of these findings on established surgical plan.

Interventions

DEVICEFlexible Bronchoscopy

Flexible Bronchoscopy

Sponsors

Henan Cancer Hospital
CollaboratorOTHER_GOV
Anhui Chest Hospital
CollaboratorOTHER
Shanghai Zhongshan Hospital
CollaboratorOTHER
Affiliated Hospital of Jiangnan University
CollaboratorOTHER
Jilin Provincial Tumor Hospital
CollaboratorOTHER
Guanxian Central Hospital of Shandong Province
CollaboratorUNKNOWN
The Third people's Hospital of Jieyang
CollaboratorUNKNOWN
Queen Mary Hospital, Hong Kong
CollaboratorOTHER
Jiangdu people's hospital of Yangzhou Jiangsu Province
CollaboratorUNKNOWN
Fudan University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

We hypothesized incidence rate that bronchoscopic findings would have changed the rate of established surgical plans as less than 2.0% (P0), then preoperative bronchoscopy examination would have limited impact on the surgical plan for GGO featured lung cancer; If bronchoscopic findings would have changed the rate of established surgical plans as more than 4.0% (P1), then bronchoscopy examination would be regarded as one routine preoperative work-up. Null hypothesis: H0: P≤P0; Alternative hypothesis: HA: P ≥ P1. α = 0.05, 1-β = 0.9. Using Simon's two-stage approach, the first phase enrolled 612 patients. If ≥18 patients supported the alternative hypothesis, they entered the second phase, otherwise the trial was terminated; the second phase enrolled 451 patients. If the patient number who eventually changes the surgical plan is ≤27, the null hypothesis is accepted, that preoperative bronchoscopy examination would be unnecessary for GGO featured lung cancer.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Ground glass opacity pulmonary nodule diagnosed by thoracic CT * karnofsky performance status ≥60 * No surgical contraindication * Patients who sign the informed consent * Pre-operation clinical stage :T1abcN0M0 * Age:18-80 years old

Exclusion criteria

* Central lung tumor diagnosed by CT * Tracheal or bronchus deformity diagnosed by CT * Tracheal or bronchus disease history * Severe smoking history (smoking index ≥400/year)

Design outcomes

Primary

MeasureTime frameDescription
Incidence rate that established surgical plan is changed by positive intra-bronchial findingsabout 14 daysThe number of patients (surgical plan is changed by positive intra-bronchial findings) /Total number of patients

Secondary

MeasureTime frameDescription
rate of positive intra-bronchial findingsabout 14 daysthe number of patients with positive intra-bronchial findings / total number of patients

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026